Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 08 Sept 2026 for Sarepta Therapeutics, Inc., €410k. Read the official filing
Filing timeline
BuySaleLouise Rodino-Klapac
Insider track record
Disclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-13.2%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Louise Rodino-Klapac: trading record in brief
This profile gathers the share dealings of Louise Rodino-Klapac in Sarepta Therapeutics, Inc., where the filings describe the role as senior executive. Between 16 November 2021 and 4 September 2026, the trades on record add up to 24 filings.
On the market, this insider has only ever bought: 1 purchase, €267k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 19 share grants and 4 option exercises.
The record was last updated on 8 September 2026 with a share grant (€410k) in Sarepta Therapeutics, Inc. The clock since the last published purchase (29 November 2021) now reads 1,784 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Louise Rodino-Klapac
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations24 total
21,423 shares@ US$22.22Common StockSEC:0001193125-26-385536:0
948 shares@ US$17.030.5% of flowCommon StockSEC:0001193125-26-106703:0
504 shares@ US$16.950.3% of flowCommon StockSEC:0001193125-26-102703:0
8,125 sharesCommon StockSEC:0001193125-26-089425:0
4,582 shares@ US$18.422.7% of flowCommon StockSEC:0001193125-25-288556:0
93,875 shares0Common StockSEC:0001193125-25-197425:0
5,500 sharesCommon StockSEC:0000950170-25-037523:0
17,500 sharesCommon StockSEC:0000950170-25-036694:0
1,704 shares@ US$101.345.8% of flowCommon StockSEC:0000950170-25-035002:0
715 shares@ US$103.772.5% of flowCommon StockSEC:0000950170-25-032759:0
4,558 shares@ US$102.8915.7% of flowCommon StockSEC:0000950170-24-129454:0
6,250 sharesCommon StockSEC:0000950170-24-077521:0
512 shares@ US$120.492.0% of flowCommon StockSEC:0000950170-24-029532:0
1,728 shares@ US$125.327.0% of flowCommon StockSEC:0000950170-24-027496:0
778 shares@ US$126.193.2% of flowCommon StockSEC:0000950170-24-026607:0
4,508 shares@ US$82.9812.1% of flowCommon StockSEC:0001209191-23-056168:0
912 shares@ US$153.194.7% of flowCommon StockSEC:0001209191-23-018021:0
1,134 shares@ US$157.215.9% of flowCommon StockSEC:0001209191-23-017407:0
522 shares@ US$147.572.6% of flowCommon StockSEC:0001209191-23-016054:0
4,211 shares@ US$108.5215.5% of flowCommon StockSEC:0001209191-22-058284:0
1,216 shares@ US$79.203.3% of flowCommon StockSEC:0001209191-22-017343:0
572 shares@ US$75.051.4% of flowCommon StockSEC:0001209191-22-014409:0
3,780 shares@ US$79.3310.0% of flowCommon StockSEC:0001209191-21-066948:0
Canonical exit: 22 Feb 2022 (T+90)
40,000 shares0Common StockSEC:0001209191-21-065314:0
24 of 24 declarations
